Olli Arjamaa, Heikki Minn. Show Affiliations »
Abstract
Mesh: See more » Angiogenesis Inhibitors/administration & dosageAngiogenesis Inhibitors/therapeutic useAntibodies, Monoclonal, Humanized/administration & dosageAntibodies, Monoclonal, Humanized/therapeutic useChoroidal Neovascularization/drug therapyFemaleHumansMacular Degeneration/drug therapyMaleTachyphylaxis
Substances: See more » Angiogenesis InhibitorsAntibodies, Monoclonal, Humanized
Year: 2012 PMID: 22510583 DOI: 10.1136/bjophthalmol-2012-301823
Source DB: PubMed Journal: Br J Ophthalmol ISSN: 0007-1161 Impact factor: 4.638